aminoimidazole carboxamide has been researched along with cyclin d1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, M; Li, H; Lin, X; Liu, Y; Lv, Z; Wan, Q; Yang, Q; Zhang, P | 1 |
Cai, B; Cai, X; Chen, X; Cheng, J; Hu, H; Hu, X; Huang, J; Jing, X; Li, Y; Tan, X; Wang, Q | 1 |
Deng, ZK; Ding, YH; Li, YF; Shi, YY; Wei, B; Wu, JJ | 1 |
3 other study(ies) available for aminoimidazole carboxamide and cyclin d1
Article | Year |
---|---|
PDGF-induced airway smooth muscle proliferation is associated with Human antigen R activation and could be weakened by AMPK activation.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antigens, Surface; Bronchi; Cell Nucleus; Cell Proliferation; Cyclin D1; ELAV Proteins; ELAV-Like Protein 1; Enzyme Activation; Flow Cytometry; Gene Silencing; Humans; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Protein Transport; Ribonucleotides; RNA-Binding Proteins | 2012 |
Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Topics: Aminoimidazole Carboxamide; Animals; Carcinoma, Hepatocellular; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Metformin; Mice; Ribonucleotides; Xenograft Model Antitumor Assays | 2013 |
[Acadesine Inhibits the Proliferation of K562 Cells and Enhances their Sensitivity to Imatinib].
Topics: Aminoimidazole Carboxamide; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Proliferation; Cyclin D1; Cyclin E; Humans; Imatinib Mesylate; K562 Cells; Oncogene Proteins; Ribonucleosides | 2016 |